If a patient with AF is at high risk of stroke, anticoagulant medication may reduce the risk by preventing a blood clot.

As suppliers provide the meters free of charge at the place of diagnosis, this means the patient receives a meter directly from a clinician in secondary care and will then receive the same brand’s testing strips in the community, regardless of whether these reflect best value. Within this there may be health inequality in patient exposure to the harms of antibiotics and the threat of antimicrobial resistance. If a trust elects not to adopt CQUIN03 as one of the five indicators in scope for their contract, they are still required to report.Despite these pregnancy prevention programme requirements, data shows ongoing exposure to valproate in pregnancy. Reduced risk of patients having ‘leftover’ antibiotics and inappropriately self-treating future infections with them or giving them to others. For some opportunities, metrics are in development to enable systems to access and view their own data and to track progress against the opportunity. Evidence of improvement in timely IVOS, monitored as a reduction in the number of IV doses dispensed (per 1,000 admissions) and the proportion of all antibiotic doses that are administered intravenously.

mmol/L, or where non-HDL cholesterol is not recorded a recording of LDL cholesterol in the preceding 12 months that is lower than 1. A year-on-year 10% reduction for the next 5 years in the number of people prescribed opioids for chronic pain for more than 3 months would save over 800 lives a year.There are no non-clinical or clinical studies on the use of aspartame in infants younger than 12 weeks of age. CQUIN snapshot audit data for percentage of patients remaining on IV antibiotics beyond the point switch criteria are met (reported quarterly), FutureNHS AMR. Horizon scanning processes are identifying medicines coming into the medicines supply pipeline early on to assess and plan opportunities for early uptake. Greater ability for trusts / systems to benchmark their uptake against neighbours or other comparable systems. Current reductions in prescribing maintained for all items that are not routinely recommended for prescribing, with no new prescribing.